BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:38 PM
 | 
Apr 18, 2007
 |  BC Extra  |  Clinical News

Avanir jumps on Zenvia data

AVNR gained $3.92 (309%) to $5.19 on 86.2 million shares on Wednesday after Zenvia met the primary endpoint in a Phase III trial to treat neuropathic...

Read the full 115 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >